Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.
------------------------------------------------------------
May 09, 2003
U.S. IMMUNIZATION NEWS
“Acambis Lands US Contract to Supply Smallpox Vaccine”
Financial Times (www.ft.com) (05/09/03) P. 24; Brun-Rovet, Marianne
British biotechnology firm Acambis enjoyed higher first-quarter sales and profits, thanks to greater U.S. demand and new government contracts for Acambis' smallpox vaccine--contracts worth 500 million pounds. The U.S. Centers for Disease Control and Prevention originally wanted Acambis to provide 54 million doses of its ACAM1000 vaccine, but then switched to the ACAM2000 vaccine instead, with Acambis providing long-term production capability and 209 million doses in all. Acambis CEO John Brown also noted that the company has a 5.89 million pound deal with the U.S. government to provide an attenuated smallpox vaccine for those with weakened immune systems.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.